免疫系统
CD80
CD86
免疫耐受
骨髓
免疫学
CD11c公司
树突状细胞
生物
癌症研究
流式细胞术
主要组织相容性复合体
PD-L1
免疫疗法
T细胞
CD40
细胞毒性T细胞
表型
体外
基因
生物化学
作者
Rubing Liu,Ruiwen Yi,Xinglu Chen,Guoguo Yi,Min Fu
标识
DOI:10.1016/j.trim.2022.101654
摘要
The side effects of immune suppressants on immune rejection have become increasingly apparent after keratoplasty. To find out new alternative immunotherapy strategies, we studied the role of programmed death-1 (PD-1) and its ligand (PD-L1) co-stimulatory pathway in inducing immune tolerance of rat keratoplasty. The PD-L1 protein was constitutively overexpressed via lentiviral transduction in bone marrow-derived dendritic cells (BMDCs) from rats, then infused via the tail vein into rats before undergoing keratoplasty. Western blot analysis of PD-L1 protein confirmed the effectiveness of lentivirus-mediated. The phenotype of immature BMDC was confirmed by flow cytometry analysis with CD80, CD86, CD11c and MHC-II antibodies. To investigate the mechanism of the immune tolerance induced by BMDCs transfusion, PD-L1, IFN-γ and IL-17 in serum and cell culture supernatant were assessed by ELISA and qPCR. After LPS stimulation, immature dendritic cells with over-expression of PD-L1 still showed high expression of PD-L1(p < 0.001), and low expression of IL-17 and IFN-γ (p < 0.001), which reduced neovascularization (p < 0.05), and prolonged the survival after corneal implants. Immature DC cells with overexpression of PD-L1 have low ability to activate T cells,which is a potential treatment for avoiding graft rejection by promoting natural immunosuppression. This cellular treatment is expected to reduce the use of immune suppressants and the occurrence of side effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI